연구
-
-
연구
-
연구업적
연구업적
최근 5년 연구업적 현황
| 연도 | 2024년 | 2023년 | 2022년 | 2021년 | 2020년 | |
|---|---|---|---|---|---|---|
| SCI 논문 발표편수 |
책임 | 179편 | 173편 | 163편 | 184편 | 135편 |
| 공동 | 147편 | 120편 | 115편 | 136편 | 168편 | |
| 합계 | 326편 | 293편 | 278편 | 320편 | 303편 | |
537. Curcumin inhibits hypoxia-inducible factor-1 by degrading aryl hydrocarbon receptor nuclear traslocator: a mechanism of tumor growth inhibition.
Hyunsung Choi, Yang-Sook Chun,Seung-Won Kim, Myung-Suk KIM, Jong-Wan Park.
Mol Pharmacol 2006 Nov;70(5)"1664-71
Link
536. NOX4 as an oxygen sensor to regulate TASK-1 activity.
Lee, Y. M. Kim, B. J. Chun, Y. S. So, I. Choi, H. Kim, M. S. Park, J. W.
Cell Signal 2006; 18(4):499-507.
Link
535. 8-hydroxydeoxyguanosine suppresses NO production and COX-2 activity via Rac1/STATs signaling in LPS-induced brain microglia.
Kim HS, Ye SK, Cho IH, Jung JE, Kim DH, Choi S, Kim YS, Park CG, Kim TY, Lee JW, Chung MH.
Free Radic Biol Med. 2006; 41(9):1392-403.
Link
534. Integrin signaling and cell spreading mediated by phorbol 12-myristate 13-acetate treatment.
Lee MS, Kim YB, Lee SY, Kim JG, Kim SH, Ye SK, Lee JW.
Journal of Cellular Biochemistry 2006,99;88-95
Link
533. Epigenetic regulation of Integrin-Linked Kinase expression depending on adhesion of gastric carcinoma cells. American Journal of Physiology-Cell Physiology.
Kim YB, Lee SY, Ye SK, Lee JW.
2006,September 20,2006.doi:10.1152/ajpcell.00169.2006
Link
531. Antitumor activity of SK-7041, a novel histone deacetylase inhibitor, in human lung and breast cancer cells.
Lee KW, Kim JH, Park JH, Kim HP, Song SH, Kim SG, Kim TY, Jong HS, Jung KH, Im SA, Kim TY, Kim NK, Bang YJ.
Anticancer Res. 2006 Sep-Oct;26(5A):3429-38.
Link
530. High fluorodeoxyglucose uptake on positron emission tomography in patients with advanced non-small cell lung cancer on platinum-based combination chemotherapy.
Lee KH, Lee SH, Kim DW, Kang WJ, Chung JK, Im SA, Kim TY, Kim YW, Bang YJ, Heo DS.
Clin Cancer Res. 2006 Jul 15;12(14 Pt 1):4232-6.
Link
529. First-line ifosfamide, methotrexate, etoposide and prednisolone chemotherapy +/- radiotherapy is active in stage I/II extranodal NK/T-cell lymphoma.
Lee KW, Yun T, Kim DW, Im SA, Kim TY, Yoon SS, Heo DS, Bang YJ, Park S, Kim BK, Kim NK.
Leuk Lymphoma. 2006 Jul;47(7):1274-82.
Link
528. Epidermal growth factor receptor mutations and response to chemotherapy in patients with non-small-cell lung cancer.
Lee KH, Han SW, Hwang PG, Oh DY, Kim DW, Chung DH, Im SA, Kim TY, Heo DS, Bang YJ.
Jpn J Clin Oncol. 2006 Jun;36(6):344-50.
Link